&#xa0;
defaultWritten Evidence submitted by Dr Roland Salmon (CJD0002)defaultWhat do you consider to be the likely prevalence of subclinical defaultvCJDdefault infection in the UK population? What evidence is there to support this defaultview?default&#xa0;
defaultHow might thdefaultis subclinical infection rate translate to future cases of defaultvCJDdefault? What are the key uncertainties in the relationship between subclinical and clinical defaultvCJDdefault?default&#xa0;
default&#xa0;
defaultWhat are the likely roudefaulttes of infection for defaultvCJDdefault? How have the potential modes of transmission changed over time?default&#xa0;
default&#xa0;
default&#xa0;
defaultWhat procedures are currently in place to monitor, defaultcontrol and prevent further spread of defaultvCJDdefault across the UK population? What more could bdefaulte done to reduce the risk posedefaultd defaultby defaultvCJDdefault?default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultOther considerationsdefault&#xa0;
default&#xa0;
defaultReferencesdefault&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultDeclaration of interestdefaultI am currently Board Member for Wales and Chair of the Welsh Food Advisory Committee for the Food Standards Agency and also a member of the Department of Health’s Advisory Committee on Dangerous Pathogens and of t
defaulthat committee’s Spongiform Encephalopathy Sub Group.  I am a member of the 
defaultConseil
default 
defaultd’Administration
default (Management Advisory Board) of the 
defaultInstitut
default de 
defaultVeille
default 
defaultSanitaire
default (French National Institute for Public Health Surveillance).
default&#xa0;
defaultNovember 2013
default&#xa0;
default